NCT04713202 2023-02-10
NET-PACS
Big Ten Cancer Research Consortium
Phase 2 Withdrawn
Clinical Trials
4 trialsNCT04672876 2021-12-17
Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors
University of Chicago
Phase 2 Withdrawn
NCT04034745 2020-12-30
Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain
Cedars-Sinai Medical Center
Withdrawn
NCT04065165 2020-02-05
TELEFIRST
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Withdrawn